Irtemazole

CAS No. 129369-64-8

Irtemazole( —— )

Catalog No. M34628 CAS No. 129369-64-8

Irtemazole (R 60844) is a novel uricosuric substance that is valuable in the treatment of hyperuricemia and gout.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 170 Get Quote
5MG 247 Get Quote
10MG 371 Get Quote
25MG 601 Get Quote
50MG 854 Get Quote
100MG 1134 Get Quote
500MG 2277 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Irtemazole
  • Note
    Research use only, not for human use.
  • Brief Description
    Irtemazole (R 60844) is a novel uricosuric substance that is valuable in the treatment of hyperuricemia and gout.
  • Description
    Irtemazole (R 60844) is a novel uricosuric substance that is valuable in the treatment of hyperuricemia and gout.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    129369-64-8
  • Formula Weight
    288.35
  • Molecular Formula
    C18H16N4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C=1C=C2C(=CC1)N=C(C)N2)(N3C=CN=C3)C4=CC=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Difenoconazole

    Difenoconazole is a broad-spectrum triazole fungicide that inhibits ergosterol biosynthesis via inhibition of the cytochrome P450-dependent 14α-demethylation of lanosterol which results in disruption of the fungal cell membrane and cell death.

  • Picfeltarraenin X

    Picfeltarraenin X shows stronger AChE inhibition than the known AChE inhibitor Tacrine.

  • Fibrinopeptide B, hu...

    FibrinopeptideB,human is a 14-amino acid polypeptide released from the amino terminus of the fibrinogen segment.